Patents Examined by Mei-Ping Chui
-
Patent number: 8216975Abstract: The present invention is directed to a method which enables the user to select a suitable soya variety as a subsequent crop to maize when weed control in that maize crop has been carried out using HPPD inhibitor herbicides in a manner that “carry-over” damage to the soya crop is thereby avoided. The method includes the step of first selecting a “reference soya” that exhibits a visually determinable phytotoxicity with respect to the HPPD inhibitor herbicide used to carry out weed control on the maize crop. Next, the phytotoxicity of various soya varieties is determined in relation to the reference soya variety in the form of a factor. This factor can be expressed, for example, in letters, numbers, symbols, colors or other visual or acoustic signals or in words. These soya varieties are then labeled with the factor and can be made accessible to the user. For example, the factor can be indicated on or inside the product packaging or in an accompanying leaflet.Type: GrantFiled: April 28, 2005Date of Patent: July 10, 2012Assignee: Syngenta Crop Protection IncInventors: Cheryl Dunne, Ulrich Johannes Haas, Michael Johnson, Willy Rüegg
-
Patent number: 8182794Abstract: Sunless tanning compositions are substantially improved by adding methylsulfonyl methane [MSM] and certain glycols to Dihydroxyacetone (DHA).Type: GrantFiled: April 1, 2006Date of Patent: May 22, 2012Inventors: John Patrick McCook, Philip J. Gordon, D. Craig Woodward
-
Patent number: 8182793Abstract: Aqueous sunless tanning formulations employed for automatic spray systems with enhanced tanning and skin moisturization properties.Type: GrantFiled: December 18, 2004Date of Patent: May 22, 2012Inventors: John Patrick McCook, Philip J. Gordon, D. Craig Woodward
-
Patent number: 8178584Abstract: The present invention relates to a water-in-oil emulsified composition containing a sphingosine represented by the following formula (1): (R1 represents a hydrocarbon group optionally having a substituent; Y represents methylene, methine or O; X1, X2 and X3 each represent H, OH or acetoxy group; X4 represents H, acetyl group or the like; R2, R3 each represents H, OH or the like; R represents H, amidino group or the like; and a stands for 2 or 3), (B) a C6-30 fatty acid, and (C) an oil component. This water-in-oil emulsified composition has excellent stability and provides a good feeling to skin upon use.Type: GrantFiled: June 9, 2004Date of Patent: May 15, 2012Assignee: Kao CorporationInventors: Koji Okubo, Yumiko Yamamoto
-
Patent number: 8148355Abstract: 3-Hydroxy-7-hydroxy steroids and 3-oxo-7-hydroxy steroids, especially the 7?-isomers thereof, and pharmaceutically acceptable esters thereof are useful for protection against ischaemia-induced damage to peripheral organs, such as the heart or kidneys, as well as treatment of spiral cord injury.Type: GrantFiled: August 13, 2002Date of Patent: April 3, 2012Assignee: Hunter-Fleming LimitedInventor: Ernst Wulfert
-
Patent number: 8138228Abstract: A liquid kelp formulation includes an enzyme inactivating component and a preservative to extend the shelf life of the formulation in terms of growth hormones. The formulation can also include a fertilizing additive, and a surfactant. A system is also provided whereby the kelp is maintained in solid form, and dissolved in water just prior to use. The solid form kelp and/or water can include additives, or additives in separate form, if used, can be added to either the kelp or the kelp solution.Type: GrantFiled: October 8, 2008Date of Patent: March 20, 2012Assignee: Accelegrow Technologies, Inc.Inventor: Louis B. Johnson
-
Patent number: 8133919Abstract: A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can be incorporated into a dry fertilizer for application using the fertilizer itself or a component of the fertilizer such as one or more of the fillers commonly used in fertilizers.Type: GrantFiled: October 14, 2008Date of Patent: March 13, 2012Assignee: Accelegrow Technologies, Inc.Inventors: Louis B. Johnson, Jeffery L. Peel
-
Patent number: 8133920Abstract: A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can also include a fertilizing additive, and a surfactant. The growth hormone can be a natural one such as that found in kelp or a synthetic one or a combination of both.Type: GrantFiled: November 25, 2008Date of Patent: March 13, 2012Assignee: Accelegrow Technologies, Inc.Inventors: Louis B Johnson, Jeffery L Peel
-
Patent number: 8124595Abstract: A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the reduction or elimination of estrogen in the initial phase is disclosed. Also described is a contraceptive kit that may be used to practice the method of the invention.Type: GrantFiled: November 12, 2004Date of Patent: February 28, 2012Assignee: Warner Chilcott Company, LLCInventor: Roger M. Boissonneault
-
Patent number: 8034385Abstract: The invention relates to a cosmetic based on various natural raw materials, which can be used to counter ageing processes of the human skin. The inventive cosmetic contains 0.1-5% by weight of an extract from a mixture of fig leaves and fruits, 0.1-3% by weight of an extract from pomegranate fruits, 0.001-0.5% by weight of a ground dry mixture of rosemary stems and leaves, 0.01-3% by weight of liposomes containing an extract from peeled musk melons, 0.1-5% by weight of liposomes containing a plankton extract containing the photolyase enzyme, 0.1-5% by weight of liposomes containing 0.1 to 0.5% by weight, in relation to the liposome weight, of a micrococcus lysate containing the UV-endonuclease enzyme; and up to 100% by weight, other active substances, carrier substances, adjuvants or mixtures thereof.Type: GrantFiled: June 23, 2003Date of Patent: October 11, 2011Assignee: Coty B.V.Inventors: Karin Golz-Berner, Leonhard Zastrow
-
Patent number: 8034798Abstract: The invention relates to a novel use of derivatives of neurosteroids, particularly pregnenolone, for the treatment of acute or chronic lesions of the nervous system, especially certain neurodegenerative diseases, related in particular to the ability thereof to stabilize and/or increase the polymerization of neuronal microtubules.Type: GrantFiled: January 16, 2004Date of Patent: October 11, 2011Assignee: MAPREGInventors: Etienne-Emile Baulieu, Esther Fellous, Paul Robel
-
Patent number: 8029770Abstract: The present invention relates to pharmaceutical compositions containing a caffeine salt complex and a pharmaceutically acceptable carrier for use in methods for preventing or treating cancer or solar dermatitis. Methods for inducing apoptosis or inhibiting proliferation in a cancer cell or cell which as UVB-induced DNA damage using a caffeine salt complex or methylated xanthine are also provided.Type: GrantFiled: February 26, 2009Date of Patent: October 4, 2011Assignee: Rutgers, The State UniversityInventors: Yaoping Lu, Allan H. Conney, YouRong Lou
-
Patent number: 7989393Abstract: Methods of treating and/or controlling algae including contacting algae with an effective amount of one or more thaxtomins are disclosed. One or more thaxtomins are applied to algae contaminated environments in a predetermined amount effective in controlling, reducing and/or killing algae.Type: GrantFiled: April 7, 2008Date of Patent: August 2, 2011Assignee: Novosymes Biologicals, Inc.Inventors: Yaowei Kang, Shawn Semones, Jonathan Leder, Anh Tran
-
Patent number: 7985412Abstract: A method of monitoring/controlling Thysanoptera (hereafter thrips) by the use of a behavior modifying compound of Formula (1), wherein Formula (1) is:— where R1 is a monoterpenyl group and R2 is a C3-C5 group.Type: GrantFiled: August 17, 2005Date of Patent: July 26, 2011Assignee: Keele UniversityInventors: James Gordon Campbell Hamilton, William Daniel John Kirk
-
Patent number: 7923440Abstract: A method of treating or preventing an immune mediated disorder in a mammal, said method comprising the administration of a therapeutically effective amount of an estrogenic component to said mammal, wherein the estrogenic component is selected from the group consisting of: substances represented by the following formula: in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R5, R6, R7 is a hydroxyl group; no more than 3 of R1, R2, R3, R4 are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors. Another aspect of the invention relates to a pharmaceutical formulation comprising the aforementioned estrogenic component, an immunotherapeutic agent and a pharmaceutically acceptable excipient.Type: GrantFiled: June 11, 2003Date of Patent: April 12, 2011Assignee: Pantarhei Bioscience B.V.Inventors: Evert Johannes Bunschoten, Herman Jan Tijmen Coelingh Bennink, Christian Franz Holinka
-
Patent number: 7906130Abstract: The present invention provides a stable composition which comprises a non-hydroxyl-group-containing solvent mixture comprising N,N-diethyl-m-toluamide and ?-hexalactone, optionally with dimethyl sulfoxide, eucalyptol and 1-methoxy-2-propyl acetate; and an effective amount of each of amitraz and at least one additional parasiticidal compound, such as R-28153. Said composition allows for high concentrations of a mixture of parasiticidal agents in a single application and is useful for treating and controlling parasiticidal infection and infestation in a homeothermic animal.Type: GrantFiled: October 7, 2005Date of Patent: March 15, 2011Assignee: Wyeth LLCInventors: Shobhan Shashi Sabnis, Jacob A. Zupan, Robert Bruce Albright
-
Patent number: 7897172Abstract: A compressible extended release tablet or tablet layer having a drug release profile that is not strongly dependent on tablet hardness may be prepared by dry blending a pharmaceutically active ingredient with hydroxypropyl methylcellulose, wherein the hydroxypropyl methylcellulose has a bimodal or multimodal number average molecular weight distribution that includes at least one mode over 20,000 Daltons and at least one mode under 10,000 Daltons. An additional advantage of the invention is that the tablet formulations may be prepared without resort to wet granulation.Type: GrantFiled: May 18, 2004Date of Patent: March 1, 2011Assignee: L. Perrigo CompanyInventors: Jaber G. Qasem, Sumner H. Cathcart, Jack T. Irwin
-
Patent number: 7825104Abstract: Phenylboronic acid and water soluble derivatives thereof and related boronic acid compounds are used for treating fungal and bacterial infections.Type: GrantFiled: July 23, 2002Date of Patent: November 2, 2010Assignee: Ramot at Tel Aviv University Ltd.Inventors: Amihay Freeman, Rina Segal, Yael Dror
-
Patent number: 7820594Abstract: This invention relates to agricultural compositions, particularly pesticidal compositions which find particular use as a fungicide or herbicide composition. The pesticidal composition can include one or more fatty acids and one or more organic acids different from the fatty acid. The organic acid can but need not exhibit any fungicidal activity; however, when combined with a fatty acid, the organic acid functions as a potent synergist for the fatty acid as a fungicide. Additionally, the pesticidal composition can include other components such as emulsifiers, adjuvants, surfactants and diluents. The pesticidal composition significantly reduces or prevents the fungal infection of cash crops including vegetables, fruits, berries, seeds, grains and at higher application rates, can also be used as a herbicide and/or harvest aid or desiccant for harvested crops such as potatoes. The addition of an emulsifier further enhances the herbicidal properties of the compositions.Type: GrantFiled: June 25, 2007Date of Patent: October 26, 2010Inventor: Robert D. Coleman
-
Patent number: 7811597Abstract: An article, such as a container or bag for garbage, which repels animals such as cats, dogs, rats, and crows. The article may be made from a synthetic resin composition including a synthetic resin and from 10 to 15,000 ppm by weight of a salicylic acid ester, menthol and/or camphor. The article may also be made from a synthetic resin composition including a synthetic resin and an odorant composition containing eucalyptus oil and one or more of a salicylic acid ester, menthol and camphor.Type: GrantFiled: September 26, 2005Date of Patent: October 12, 2010Assignee: JAD Corporation of AmericaInventors: Masahiko Katoh, Joseph Dussich